Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $568.7300 (5.22%) ($539.1400 - $572.3000) on Fri. Apr. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.81% (three month average) | RSI | 87 | Latest Price | $568.7300(5.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 2.2% a day on average for past five trading days. | Weekly Trend | REGN advances 5.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(56%) XLV(46%) IVW(37%) IWF(36%) SPLV(36%) | Factors Impacting REGN price | REGN will decline at least -1.905% in a week (0% probabilities). VIXM(-20%) VXX(-7%) UUP(-6%) TBT(-5%) IYT(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.905% (StdDev 3.81%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $532.79(6.75%) | 10 Day Moving Average | $519.84(9.4%) | 20 Day Moving Average | $493.07(15.34%) | To recent high | 0% | To recent low | 69.2% | Market Cap | $60.302b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |